The emerging therapy of the medication represents a major advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide affects dual pathways – the GLP-1 hormone and the GIP hormone – leading https://tirzepatidepeptide714630.webbuzzfeed.com/42366296/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment